Afrezza Sale, or Afrezza Sales ??

[rockstarrick]

Afrezza sale, or Afrezza sales ??
I just wanted to see how the majority of MNKD Longs feel about either,
1) Mannkind trying to market Afrezza, (with or without help) throughout the USA to see what sales look like when the Company is actually trying to sell the product.
2) Mannkind selling Afrezza to the highest bidder, to fund the Research and Development of our Technosphere Technology.
I know it's really frustrating to MNKD longs who have held for several years, but after almost 2 years since FDA approval, we really don't know how BIG Afrezza sales will be with a full blown DTC Campaign and aggressive Marketing campaign. In my opinion, Sanofi did everything they could to make sure Afrezza sales would be consistantly poor so they could buy, (or steal) Afrezza cheap. After they realized Al wasn't going to put up with their sandbagging tactics, they either chose to, or were forced, to end the partnership at the earliest date possible.
My question to MNKD longs. How would you feel if MNKD sold Afrezza to the highest bidder, ($5 to $10/share for example) only to watch Afrezza reach Mega Blockbuster status quickly after the buyer implemented a Real DTC and Marketing campaign ?? It could happen !! We really don't know how well Afrezza will sell at this point, we only know that the few that have tried Afrezza, for the most part, love it.
Myself, I hope Mannkind does attempt to market Afrezza long enough to get a better idea of what it's worth before selling it, and I would gladly risk everything I have invested, because I strongly believe Afrezza will become the #1 mealtime insulin product for many years to come. Please think about how much money we may be leaving on the table if we sell Afrezza at this point, and the possibilities if we don't.

Would you like to see Mannkind sell Afrezza to the highest bidder, and why ??
or
Would you like to see Mannkind attempt to market Afrezza, with or without help, to regain some of our value before considering selling,
and why ??

Thanks

[liane]

I absolutely do not want Afrezza sold now, and hopefully never. I know, medically, what this drug is capable of. But it needs a competent, aggressive marketing campaign. I am willing to risk everything I have invested in MNKD so far, and then some. Final answer!

[sportsrancho]

I think we can sell more than SNY did! Let's go for it. Just a whiff of a recovery and I think we will have all kinds of bidders. They won't be able to afford not too!

[fedakd]

They can have my shares for $6, or just under $3B. Seems quite fair. I'm tired of this, it's time to sell the company.

[saxcmann]

Sell to highest bidder. I'm happy with $5-10 bucks. Move on to something else maybe oil. Learned how corrupt and manipulative WS is!

[rockstarrick]

Mar 9, 2016 18:06:43 GMT -5 liane said:

I absolutely do not want Afrezza sold now, and hopefully never. I know, medically, what this drug is capable of. But it needs a competent, aggressive marketing campaign. I am willing to risk everything I have invested in MNKD so far, and then some. Final answer!

I'm right there with you, I just don't think Afrezza will be that hard to sell.  With the right DTC and marketing campaign, I can see Afrezza as one of the biggest advancements in Diabetes care since the discovery of Insulin.  What a shame it would be to lose that after all these years.  
I have to think Al would never let that happen, and he took all the necessary steps to ensure the success of Afrezza before he passed.
Ill be here as long as it takes.
Good Luck Liane.

[anderson]

If MNKD is successful in marketing Afrezza this lays the ground work for all the other drugs they are developing. Whats the old saying, "If you want it done right you have to do it yourself."

[fedakd]

Problem is MNKD doesn't have the cash to do it themselves. Afrezza needs to be sold ASAP to a company with deep pockets that will get behind it. There's no other way. Hopefully they are just dotting the I's now.

[jurystillout]

Sounds like your assuming that there is a buyer our there willing and able to buy afrezza, I don't believe there is. Right now mnkd has no choice but to go it alone, hopefully they will be able to show the product for what it is and generate a growing customer base so a big pharma will see the value/potential and make an offer however it won't happen until mnkd proves it can be done at least to some degree.

[rockstarrick]

Matt stated their were 2 other companies wanting in when they signed the agreement with Sanofi, I would imagine the package is more attractive now than it was then, Other than sales and marketing, Sanofi did get some work done, right.  To think that no one is interested in Afrezza is reaching a little IMO.
opinions vary.
good luck

[coco]

I'm with Liane. We have come this far to what sell out cheap only to have some other company get rich off Afrezza. I say we wait, at least for now and see what happens. A lot can happen after April 5 th.

[bioexec25]

Mar 10, 2016 1:53:51 GMT -5 coco said:

I'm with Liane. We have come this far to what sell out cheap only to have some other company get rich off Afrezza. I say we wait, at least for now and see what happens. A lot can happen after April 5 th.

I'm in the let's try to do it ourselves camp but I'm fine with giving up some or all of a region to secure upfront cash. It's a big world out there with a huge and growing diabetic population. So it's an AND not an OR. Keep it but sell some to insure survival for a couple of years. By then this story is told, epic or not.

[patten1962]

If you longs sell at $6 and break even IMHO you will be kicking yourself in the ass in 2 years. Anyone see 2017 calls now have a $15 strike! Just saying!

[liane]

Those Jan17 $15 calls are nothing new; the open interest in them has been growing for the past year. My guess is that they are being sold as part of a call spread.

[wiscdh]

Selling Afrezza to the highest bidder seems to be the 'easy way out' but as we have all learned, the only thing easy about Afrezza is how you use it. There is no denying the results of Afrezza and with the right marketing it should sell very well in the US and around the world. Al stated many times that if we take care of the patient, everything else will fall into place or something like that. 

I would like Mannkind to keep Afrezza and market the heck out of it and see what happens. I know the cash situation needs to be addressed but where there's a will there's a way and I am confident that management will find a way.